Patient and transplant characteristics of modified intention-to-treat population.
RAEB, AML, CLL, ALL, NHL
ACUTE MYELOID LEUKEMIA, CLL, B CHRONIC LYMPHOCYTIC LEUKEMIA, MYELODYSPLASTIC SYNDROME, AML, MYELOFIBROSIS, ACUTE LYMPHOBLASTIC LEUKEMIA, NON-HODGKIN LYMPHOMA, NHL, RAEB, REFRACTORY ANEMIA WITH EXCESS BLASTS-1
ALL: acute lymphoblastic leukemia; AML: acute myeloid leukemia; NHL: non-Hodgkin lymphoma; CLL: chronic lymphocytic leukemia; MDS: myelodysplastic syndrome; MYF: myelofibrosis; RAEB: refractory anemia with excess blasts; RIC: reduced intensity conditioning; SD: standard deviation.*P value<0.05.Before transplant, mean 25(OH)D levels did not differ between two groups (high Vit D vs. Control (nmol/L): 67±28.1 vs. 71 ±21.9, p = 0.42) (